Intelligence Profile
Clinical Applications
Humanin is a mitochondrial-derived peptide being investigated across multiple clinical conditions, though most evidence comes from preclinical studies with limited human clinical trial data available.
Conditions Under Investigation
Diabetes and Metabolic Disorders
Research suggests humanin may help address diabetes-related complications. In animal models, humanin has been shown to ameliorate testicular damage caused by diabetes and restore metabolic hormone balance, including leptin, ghrelin, irisin, and asprosin levels in diabetic mice. However, human clinical evidence for these applications remains limited.
Retinal and Ocular Conditions
Humanin shows potential for treating retinal degeneration and age-related eye diseases. Studies indicate it may protect retinal pigment epithelium cells from damage and provide neuroprotective effects in models of retinal degeneration, though these findings are primarily from animal research.
Reproductive Health
Emerging research explores humanin's role in protecting reproductive cells. Studies have investigated its protective effects on granulosa cells under oxidative stress conditions and as a potential indicator of semen quality and cryotolerance, though clinical applications in human reproductive medicine are not yet established.
Respiratory Conditions
Preliminary research suggests humanin may have therapeutic potential in acute respiratory distress syndrome (ARDS) through cytoprotective mechanisms, though this remains in early investigational stages.
Current Clinical Trials
Three clinical trials are examining humanin in human patients:
- A completed observational study investigating humanin levels in cardiac surgery patients
- Studies examining plasma humanin levels in acute kidney injury and during different anesthesia approaches in kidney transplant patients
Clinical Evidence Limitations
The clinical evidence for humanin remains primarily preclinical, with most research conducted in animal models or cell cultures. While early findings suggest potential therapeutic benefits across multiple conditions, robust human clinical trial data demonstrating safety and efficacy is currently lacking. The transition from promising preclinical results to proven clinical applications requires additional rigorous human studies.
This information is for educational purposes only and should not be considered medical advice. Consult healthcare providers for guidance on specific medical conditions.